SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    I. Fernández-Burgos, M.C. Montiel Casado, J.A. Pérez-Daga, J.M. Aranda-Narváez, B. Sánchez-Pérez, F.J. León-Díaz, M. Cabello-Díaz, D. Rodríguez-Burgos, D. Hernández-Marrero, J. Santoyo-Santoyo, Induction Therapy in Simultaneous Pancreas-Kidney Transplantation: Thymoglobulin Versus Basiliximab, Transplantation Proceedings, 2015, 47, 1, 120

    CrossRef

  2. 2
    Robert J Stratta, Alan C Farney, Jeffrey Rogers, Giuseppe Orlando, Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective, Expert Review of Clinical Immunology, 2014, 10, 1, 117

    CrossRef

  3. 3
    Joshua M. Rosenblum, Allan D. Kirk, Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy, Immunological Reviews, 2014, 258, 1
  4. 4
    Erika B Rangel, Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug–drug interactions, Expert Opinion on Drug Metabolism & Toxicology, 2014, 10, 11, 1585

    CrossRef

  5. 5
    Silke V. Niederhaus, Dixon B. Kaufman, Jon S. Odorico, Induction therapy in pancreas transplantation, Transplant International, 2013, 26, 7
  6. 6
    G. Ciancio, J. Sageshima, L. Chen, J. J. Gaynor, L. Hanson, L. Tueros, E. Montenora Velarde, C. Gomez, W. Kupin, G. Guerra, A. Mattiazzi, A. Fornoni, A. Pugliese, D. Roth, M. Wolf, G. W. Burke III, Advantage of Rapamycin Over Mycophenolate Mofetil When Used With Tacrolimus for Simultaneous Pancreas Kidney Transplants: Randomized, Single-Center Trial at 10 Years, American Journal of Transplantation, 2012, 12, 12
  7. 7
    Anja Püschel, Nicole Lindenblatt, Juliane Katzfuß, Brigitte Vollmar, Ernst Klar, Immunosuppressants accelerate microvascular thrombus formation in vivo: Role of endothelial cell activation, Surgery, 2012, 151, 1, 26

    CrossRef

  8. 8
    Cyrus Jahansouz, Sean C. Kumer, Michael Ellenbogen, Kenneth L. Brayman, Evolution ofβ-Cell Replacement Therapy in Diabetes Mellitus: Pancreas Transplantation, Diabetes Technology & Therapeutics, 2011, 13, 3, 395

    CrossRef

  9. You have free access to this content9
    B. L. Gala-Lopez, P. A. Senior, A. Koh, S. M. Kashkoush, T. Kawahara, T. Kin, A. Humar, A. M. J. Shapiro, Late Cytomegalovirus Transmission and Impact of T-Depletion in Clinical Islet Transplantation, American Journal of Transplantation, 2011, 11, 12
  10. 10
    Asunción Moreno Camacho, Alberto Rodríguez Benot, Profilaxis de la infección por citomegalovirus en el trasplante de páncreas, Enfermedades Infecciosas y Microbiología Clínica, 2011, 29, 56

    CrossRef

  11. 11
    Robert J. Stratta, Carolynn Pietrangeli, G. Mark Baillie, Defining the Risks for Cytomegalovirus Infection and Disease After Solid Organ Transplantation, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010, 30, 2
  12. 12
    Raymond L. Heilman, Marek J. Mazur, K. Sudhakar Reddy, Immunosuppression in Simultaneous Pancreas-Kidney Transplantation, Drugs, 2010, 70, 7, 793

    CrossRef

  13. 13
    Steve A White, James A Shaw, David ER Sutherland, Pancreas transplantation, The Lancet, 2009, 373, 9677, 1808

    CrossRef

  14. 14
    Rubin Zhang, Sander Florman, Anil Paramesh, Tareq Islam, April Zarifian, Eric Simon, L Lee Hamm, Douglas Slakey, Pancreas Transplantation in African American Patients Using Basiliximab Induction, The American Journal of the Medical Sciences, 2009, 337, 5, 307

    CrossRef

  15. 15
    N. Issa, H. Amer, P. G. Dean, W. K. Kremers, Y. C. Kudva, N. Rostambeigi, F. G. Cosio, T. S. Larson, T. M. Habermann, M. D. Stegall, M. D. Griffin, Posttransplant Lymphoproliferative Disorder Following Pancreas Transplantation, American Journal of Transplantation, 2009, 9, 8
  16. 16
    Susan M. Lerner, Kidney and pancreas transplantation in type 1 diabetes mellitus, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2008, 75, 4
  17. 17
    Avinash Agarwal, Luke Y. Shen, Allan D. Kirk, The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation, Transplant Immunology, 2008, 20, 1-2, 6

    CrossRef

  18. 18
    R. Zhang, S. Florman, S. Devidoss, A. Zarifian, C. L. Yau, A. Paramesh, M. Killackey, B. Alper, V. Fonseca, D. Slakey, A Comparison of Long-Term Survivals of Simultaneous Pancreas–Kidney Transplant between African American and Caucasian Recipients with Basiliximab Induction Therapy, American Journal of Transplantation, 2007, 7, 7
  19. 19
    Supha K. Arthurs, Albert J. Eid, Rachel A. Pedersen, Ross A. Dierkhising, Walter K. Kremers, Robin Patel, Raymund R. Razonable, Delayed-onset primary cytomegalovirus disease after liver transplantation, Liver Transplantation, 2007, 13, 12
  20. 20
    Rubin Zhang, Sandy Florman, Sharmila Devidoss, April Zarifian, Mary Killackey, Anil Paramesh, Vivian Fonseca, Vecihi Batuman, L. Lee Hamm, Douglas Slakey, The long-term survival of simultaneous pancreas and kidney transplant with basiliximab induction therapy, Clinical Transplantation, 2007, 21, 5
  21. 21
    B.M. Schmied, S.A. Müller, A. Mehrabi, Th Welsch, M.W. Büchler, M. Zeier, J Schmidt, Immunosuppressive standards in simultaneous kidney–pancreas transplantation, Clinical Transplantation, 2006, 20,
  22. 22
    Allan D. Kirk, Induction Immunosuppression, Transplantation, 2006, 82, 5, 593

    CrossRef

  23. 23
    D. J. Cohen, L. St. Martin, L. L. Christensen, R. D. Bloom, R. S. Sung, Kidney and Pancreas Transplantation in the United States, 1995–2004, American Journal of Transplantation, 2006, 6, 5p2
  24. 24
    Ngoc Thai, Pancreatic Transplantation, 2006,

    CrossRef

  25. 25
    Muhammad M. Hafiz, Raquel N. Faradji, Tatiana Froud, Antonello Pileggi, David A. Baidal, Pablo Cure, Gaston Ponte, Raffaella Poggioli, Agustin Cornejo, Shari Messinger, Camillo Ricordi, Rodolfo Alejandro, Immunosuppression and Procedure-Related Complications in 26 Patients with Type 1 Diabetes Mellitus Receiving Allogeneic Islet Cell Transplantation, Transplantation, 2005, 80, 12, 1718

    CrossRef

  26. 26
    Dixon B Kaufman, Paolo R. O Salvalaggio, Immunosuppression for pancreas transplantation, Current Opinion in Organ Transplantation, 2005, 10, 2, 169

    CrossRef

  27. 27
    Francesca M Egidi, Management of Hyperglycaemia After Pancreas Transplantation, Drugs, 2005, 65, 2, 153

    CrossRef

  28. 28
    David B. Leeser, Stephen T. Bartlett, Evolving surgical strategies for pancreas transplantation, Current Diabetes Reports, 2004, 4, 4, 310

    CrossRef

  29. 29
    Dixon B. Kaufman, Ron Shapiro, Michael R. Lucey, Wida S. Cherikh, Rami T. Bustami, David B. Dyke, Immunosuppression: practice and trends, American Journal of Transplantation, 2004, 4,
  30. 30
    David L. Bigam, A. M. James Shapiro, Pancreatic transplantation: Beta cell replacement, Current Treatment Options in Gastroenterology, 2004, 7, 5, 329

    CrossRef

  31. 31
    Ali H. Charafeddine, Allan D. Kirk, Induction Immunosuppressive Therapy,
  32. 32
    Avinash Agarwal, David Bruno, Stuart J. Knechtle, The Role of Alemtuzumab in Solid Organ Transplantation,